Stay updated on Brain Metastasis Steroids Clinical Trial
Sign up to get notified when there's something new on the Brain Metastasis Steroids Clinical Trial page.

Latest updates to the Brain Metastasis Steroids Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record describes a trial of immunotherapy for melanoma that has spread to the brain in patients receiving steroids. It provides the treatment arms, eligibility criteria, recruiting locations, contacts, and outcome measures.SummaryDifference71%

- Check19 days agoChange DetectedThe record describing a study of immunotherapy for melanoma with brain metastases has been replaced by a 403 Forbidden page, removing details about its treatments, eligibility, outcomes, and study locations.SummaryDifference21%

- Check26 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the page displaying a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, and the layout presents a generic error page with standard navigation and footer elements.SummaryDifference21%

Stay in the know with updates to Brain Metastasis Steroids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brain Metastasis Steroids Clinical Trial page.